Galera Therapeutics Inc.

AI Score

0

Unlock

0.05
0.00 (8.46%)
At close: Jan 15, 2025, 8:00 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -0.11 -0.65 -1.35 -3.43 -6.29 -9.81 -7.76
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -0.05 -0.37 -2.04 41.59 4.69 -2.22 -2.4
P/FCF Ratio -0.14 -0.93 -1.73 -4.24 -6.9 -10.32 -7.7
P/OCF Ratio -0.14 -0.93 -1.74 -4.27 -7 -10.48 -7.8
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.01 -0.00 -0.01 0.09 0.01 -0.19 n/a
Quick Ratio 4.36 2.88 5.98 5.58 12.13 13.01 3.53
Current Ratio 4.36 2.88 5.98 5.58 12.13 13.01 3.53
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage n/a -4.43 -10.2 -14.46 -16.72 -110.25 n/a
Return on Equity (ROE) 0.45 0.57 1.51 -12.13 -0.75 0.23 0.31
Return on Assets (ROA) -2.26 -1.41 -1.05 -0.88 -0.42 -0.27 -1.25
Return on Capital (ROIC) -2.22 -1.67 -1.04 -1.01 -0.45 -0.3 -1.65
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a